BACKGROUND: Neovascular membranes obtained from surgical excision of neovascularization for retinal angiomatous proliferation (RAP) were examined histopathologically in an attempt to elucidate the pathogenic mechanism of RAP. METHODS: Nine eyes of eight patients (mean age, 79 +/- 6 years) who underwent neovascularization excision were studied. Three eyes had stage II with RPE detachment, six had stage III. Immunohistochemical studies were performed to identify von Willebrand factor, vascular endothelial factor (VEGF), CD68 and hypoxia inducible factors (HIF-1 alpha and HIF-2 alpha). RESULTS: Multiple soft drusen were present in the macular area in all patients. In one stage II eye, we observed intraretinal neovascularization as a VEGF-positive mass, CD68-positive macrophage migration and HIF expression. In another stage II eye, neovascularization had extended above the RPE, while VEGF-positive fibroblasts were observed below the RPE. Therefore, in stage II, neither angiographic nor histopathological examinations identified choroidal neovascularization. In one phase III eye, angiography demonstrated choroidal neovascularization and chorioretinal anastomosis. Histopathologically, chorio-retinal communication was observed in the region where the RPE was destroyed, and VEGF-positive neovascularization was also seen below the RPE. CONCLUSIONS: The findings of multiple drusen in elderly patients together with macrophage migration and HIF expression surrounding VEGF-positive retinal neovascularization suggest ischemic and inflammatory factors to be associated with the development and progression of RAP.
BACKGROUND: Neovascular membranes obtained from surgical excision of neovascularization for retinal angiomatous proliferation (RAP) were examined histopathologically in an attempt to elucidate the pathogenic mechanism of RAP. METHODS: Nine eyes of eight patients (mean age, 79 +/- 6 years) who underwent neovascularization excision were studied. Three eyes had stage II with RPE detachment, six had stage III. Immunohistochemical studies were performed to identify von Willebrand factor, vascular endothelial factor (VEGF), CD68 and hypoxia inducible factors (HIF-1 alpha and HIF-2 alpha). RESULTS: Multiple soft drusen were present in the macular area in all patients. In one stage II eye, we observed intraretinal neovascularization as a VEGF-positive mass, CD68-positive macrophage migration and HIF expression. In another stage II eye, neovascularization had extended above the RPE, while VEGF-positive fibroblasts were observed below the RPE. Therefore, in stage II, neither angiographic nor histopathological examinations identified choroidal neovascularization. In one phase III eye, angiography demonstrated choroidal neovascularization and chorioretinal anastomosis. Histopathologically, chorio-retinal communication was observed in the region where the RPE was destroyed, and VEGF-positive neovascularization was also seen below the RPE. CONCLUSIONS: The findings of multiple drusen in elderly patients together with macrophage migration and HIF expression surrounding VEGF-positive retinal neovascularization suggest ischemic and inflammatory factors to be associated with the development and progression of RAP.
Authors: L A Yannuzzi; S Negrão; T Iida; C Carvalho; H Rodriguez-Coleman; J Slakter; K B Freund; J Sorenson; D Orlock; N Borodoker Journal: Retina Date: 2001 Impact factor: 4.256
Authors: J E Grunwald; S M Hariprasad; J DuPont; M G Maguire; S L Fine; A J Brucker; A M Maguire; A C Ho Journal: Invest Ophthalmol Vis Sci Date: 1998-02 Impact factor: 4.799
Authors: R S Ramrattan; T L van der Schaft; C M Mooy; W C de Bruijn; P G Mulder; P T de Jong Journal: Invest Ophthalmol Vis Sci Date: 1994-05 Impact factor: 4.799
Authors: Steven N Truong; Suhail Alam; Robert J Zawadzki; Stacey S Choi; David G Telander; Susanna S Park; John S Werner; Lawrence S Morse Journal: Retina Date: 2007-09 Impact factor: 4.256
Authors: Carl M Sheridan; Stephanie Pate; Paul Hiscott; David Wong; David M Pattwell; David Kent Journal: Graefes Arch Clin Exp Ophthalmol Date: 2009-07-10 Impact factor: 3.117
Authors: Stefan Sacu; Katharina Eibenberger; Doreen Schmidl; Sandra Rezar-Dreindl; Gerhard Garhöfer; Jonas Brugger; Wolf Buehl; Leopold Schmetterer; Ursula Schmidt-Erfurth Journal: PLoS One Date: 2022-07-12 Impact factor: 3.752
Authors: Mingkai Lin; Yang Hu; Ying Chen; Kevin K Zhou; Ji Jin; Meili Zhu; Yun-Zheng Le; Jian Ge; Jian-Xing Ma Journal: Invest Ophthalmol Vis Sci Date: 2012-09-14 Impact factor: 4.799
Authors: Eiichi Hasegawa; Harry Sweigard; Deeba Husain; Ana M Olivares; Bo Chang; Kaylee E Smith; Amy E Birsner; Robert J D'Amato; Norman A Michaud; Yinan Han; Demetrios G Vavvas; Joan W Miller; Neena B Haider; Kip M Connor Journal: PLoS One Date: 2014-09-04 Impact factor: 3.240